10.25.2023 OMA Board Book

OMA 2023

OMA Board of Trustees Board Meeting Book

October 25 , 2023 CONTENT CONFIDENTIAL – DO NOT SHARE CONTENT OUTSIDE OMA

Board of Trustees (BOT) Meeting San Jacinto Conference Room 2 nd Floor Grand Hyatt San Antonio River Walk

San Antonio, TX October 25, 2023 1:00-5:00 PM CT

Zoom Information: https://obesitymedicine-org.zoom.us/j/85644130511?pwd=RGRtUHorU3QvK3VwQVdDOVNlSlE5QT09 Meeting ID: 856 4413 0511 Passcode: 012153

Presiding Officer: Dr. Angela Fitch

Time

Topic

Lead Fitch

Action

Documents

1:00 PM

Call to Order and Opening Remarks

1:01 PM 1:03 PM 1:05 PM 1:10 PM

Roll Call

Censani

Approval of the Agenda

Fitch Fitch Fitch

Vote

Conflict of Interest Disclosures Approval of the Consent Agenda and Supporting Documents Past Progress and Future Plans for Obesity Pillars Finalization of the OMA’s Four Pillars Nomenclature ACLM + OMA (+ other societies) Clinical Practice Guidelines (CPGs) for Type II Diabetes Collaboration Finance Committee Report

Discussion

4 - 10 11 - 38

Vote

1:15 PM

Bays, Cuda

Information

39 - 41

1:35 PM

Fitch, Alexander

Vote

42 - 47

1:50 PM

Censani

Vote

48 - 134

2:00 PM

Alexander

Information

135 - 140

OMA Bylaws Changes Communication Plan Considerations

2:10 PM

Fitch, Fraker

Discussion

141 - 147

Council of Medical Specialty Societies (CMSS) Membership for 2024

2:30 PM

Fitch

Vote

148 - 152

2:40 PM

BOT Membership Policy Development

Fitch

Vote

153

2:45 PM

2024 “Fall-Focused” Conference Educational Programming Plan

Fitch, Fraker

Discussion

154- 165

3:00 PM 3:15 PM

Break

Local Obesity Group and Affiliations with the OMA

Auriemma, Fraker

Discussion

166 - 169

3:35 PM

Strategic Plan Progress for 2023

Fraker

Discussion

170 - 181

and Strategic Plan for 2024

International Obesity Coalition (IOC) Advocacy Documents: Obesity Treatment versus Weight Loss and BMI Consensus Statements December 2023 BOT Meeting Date Choices: 12/13/2023 5:00-7:00 PM ET or 12/18/2023 5:000-7:00 PM ET Generative Discussion/Open Forum

3:45 PM

Fitch

Vote

182 - 184

3:55 PM

Fraker

Discussion

185

4:00 PM

Fitch

Discussion

185

4:30 PM 4:45 PM 5:00 PM

Executive Session

Fitch Fitch Fitch

Discussion Discussion

185 185

New Business

Call to Adjourn and Closing Remarks

Product

Company

Description

Type

Relationship

Board Member

CinRX is a biotech company founded in 2015 that is focused on the drug development sector.

Angela Fitch

Pharmaceuticals

CinRX

Pharmaceutical

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Advisory Board & Speakers Bureau

Pharmaceutical

Eli Lilly

Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Knownwell Inc. is a healthcare delivery company Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Sidekick is a social health game. It is designed to motivate and engage people towards a healthy lifestyle. Sidekick allows people to communicate, collaborate and compete with friends and colleagues, while improving their lifestyle. Suvie builds a multi-zone cool to cook kitchen robot that makes 5 star meals with zero effort. Ms.Medicine is an innovative health care organization whose mission is to raise the standard of care of women’s health. Diet Program

Biotechnology, Medical Device, diabetes

Pharmaceuticals

Gelesis

Advisory Board

Pharmaceuticals

Knownwell Inc.

Biotechnology

Stock Ownership

Pharmaceuticals

Merck

Biotechnology, pharmaceutical

Editor

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical

Advisory Board

Behavior App

Biotechnology

Sidekick Health

Nutrition

Jenny Craig

Food and beverage

Science Advisory Board

Nutrition

Suvie

Food and beverage

Advisor

Turn-Key Business Solutions MsMedicine

Health Care

Advisory Board

FoundHealth.com offers information to help patients discover a range of treatments for their health challenges Health Care

Turn-Key Business Solutions Found Health

Advisory Board

This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers.

Harvard Blackburn Obesity Medicine

Education

Education

Co-Director

The American College of Physicians (ACP) is a national organization of internists, who specialize in the diagnosis, treatment, and care of adults Association

501C-6 / 501C-3 Organizations

American College of Physicians (ACP)

Member

The American Society for Metabolic and Bariatric Surgery (ASMBS) is the largest national society for this specialty. The vision of the Society is to improve public health and well being by lessening the burden of the disease of obesity and related diseases throughout the world. The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity.

501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations

American Society of Metabolic and Bariatric Surgery (ASMBS)

Association

Member

General Member, planning committee

The Obesity Society (TOS)

Association

Product

Company

Company Description

Type

Relationship

Board Member

Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity.

Ethan Lazarus

Pharmaceutical

Currax

Pharmaceutical

Speaker, Advisory Board

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Advisory Board - MAY 18th and 19th 2023

Pharmaceutical

Eli Lilly

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity.

Pharmaceutical

NovoNordisk

Biotechnology, pharmaceutical

Speakers Bureau

Consultant in development of hyperphagia assessment tool

Pharmaceutical

Rhythm Pharmaceuticals

Biotechnology, pharmaceutical

Nestlé Health Science is a leader in the field of nutritional science, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer health, medical nutrition and supplement brands. This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers. The American Academy of Family Physicians (AAFP) was founded in 1947 to promote and maintain high quality standards for family medicine, an offshoot of the classical general practitioner. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” The Colorado Medical Society (CMS) is the largest group of organized physicians in Colorado. This nonprofit organization is Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. The American College of Lifestyle Medicine (ACLM) is the medical professional society providing quality education and certification to those dedicated to clinical and worksite practice of lifestyle medicine as the foundation of a transformed and sustainable health care system. Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. Company Description

Nutrition

Nestle Nutrition

Food and beverage

Advisory Board/Speaker

Harvard Blackburn Obesity Medicine

Education

Education

Presenter

501C-6 / 501C-3 Organizations

American Academy of Family Physicians

Association

Member

501C-6 / 501C-3 Organizations

American Medical Association (AMA)

Association

Member, Delegate for OMA

composed of physicians, residents and medical students. It was founded in 1871 to promote the art and science of medicine and to improve public health. Association

501C-6 / 501C-3 Organizations

Member

Colorado Medical Society

Product

Company

Type

Relationship

Board Member

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Lydia Alexander

Pharmaceutical

Eli Lilly

Speakers Bureau

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical

Advisory Board

Harvard Blackburn Obesity Medicine

Obesity Medicine Course Lecturer

Education

Education

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly

Speakers Bureau

SELECT Obesity National Advisory Board

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical

501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations

American Medical Association (AMA)

Association

Member

The Obesity Society (TOS)

Association

Member

The American College of Physicians (ACP) is a national organization of internists, who specialize in the diagnosis, treatment, and care of adults Association

501C-6 / 501C-3 Organizations

American College of Physicians (ACP)

Member

501C-6 / 501C-3 Organizations

American College of Lifestyle Medicine

Association

Member

Corporation

Consultant

Surgical

Intuitive Surgical

Enara Health is a holistic weight management platform that is building an expansive healthcare network to scale medical obesity treatment.

Biotechnology

Enara Health

Biotechnology platform

Stock Ownership

Product

Company

Company Description

Type

Relationship

Board Member

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Allergan plc is an American, Irish domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. Medical devices in major areas (e.g. cardiovascular, neurology, orthopedic) Minimally invasive – surgery technologies including robotics and tracking Medical equipment: therapeutic and diagnostic Health and personal Care products Medical IT and healthcare web applications Aesthetic-medical technologies Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide based therapeutics for the treatment of obesity and liver diseases. Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California Anji Pharma is a clinical-stage biotech company with operations in the U.S., Beijing, and Shanghai. AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines. Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Biohaven is a clinical-stage biopharmaceutical company with proven leadership in industry and academic settings. Bionime was established in April 2003 with the goal of improving the lives of people with diabetes through better self-monitoring. Bionime is focused on designing and manufacturing accurate medical testing equipment. Boehringer Ingelheim is a pharmaceutical company that develops innovative healthcare products for both human & animal needs. CinCor is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic and kidney diseases CSL Behring is a biopharmaceutical company, manufacturing plasma derived and recombinant therapeutic products

Received Grant, Consultant/Advisor

Harold Bays

Pharmaceuticals

89Bio

Biopharmaceutical

Pharmaceutical

Received Grant

Pharmaceuticals

Allergan

Devices, therapeutics

Received Grant

Pharmaceuticals

Alon Medteck/Epitomee

Received Grant, Consultant/Advisor

Pharmaceuticals

Altimmune

Biopharmaceutical

Received Grant, Consultant/Advisor

Pharmaceuticals

Amgen

Biopharmaceutical

Pharmaceuticals

Anji Pharma

Biotech

Received Grant

Pharmaceuticals

AstraZeneca

Biopharmaceutical

Received Grant

Pharmaceuticals

Axsome

Biopharmaceutical

Received Grant

Pharmaceuticals

BioHaven

Biopharmaceutical

Received Grant

Biotechnology

Received Grant

Pharmaceuticals

Bionime

Biotechnology, Medical, Pharmac eutical

Received Grant, Consultant/advisor

Pharmaceuticals

Boehringer Ingelheim

Pharmaceutical

CinCor

Biopharmaceutical

Received Grant

Pharmaceutical

CSL Behring

Biopharmaceutical

Received Grant

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Received Grant, Consultant/advisor

Pharmaceutical

Eli Lilly

Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C.

Received Grant, Consultant/Advisor

Pharmaceutical

Esperion

Pharmaceutical

Evidera provides evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products A metabolic therapeutics company focused on pioneering new approaches for the treatment of metabolic diseases, including type 2 diabetes and obesity. Their goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of T2D and obesity. Gan & Lee Pharmaceuticals is a leading pharmaceutical company in China specializing in the development, production, and commercialization of recombinant insulin analogs and injection pens,* with plans to expand globally. Kallyope, Inc. is a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis. Madrigal is a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases. Matinas Biopharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on redefining the intracellular delivery of nucleic acids and small molecules through its lipid nanocrystal (LNC) drug delivery platform. Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Pfizer is a pharmaceuticals and biotechnology company. Regerenron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. We are a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions. Selecta Biosciences is a clinical stage biotechnology company with a commitment to solving the challenges associated with autoimmunity and unwanted immunogenicity through our pioneering ImmTOR® precision immune tolerance platform. Shionogi Inc. is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs.

Biopharmaceutical, biotechnology

Pharmaceutical

Evidera

Received Grant

Biopharmaceutical, biotechnology

Received Grant

Fractyl

Biotechnology

Pharmaceutical

Received Grant

Pharmaceutical

Gan and Lee

Biotechnology

Received Grant

Biotechnology

Kallyope

Pharmaceutical

Madrigal

Biopharmaceutical

Received Grant

Biopharmaceutical

Received Grant

Pharmaceutical

Matinas

Pharmaceutical

Merck

Biotechnology, pharmaceutical

Received Grant

NewAmsterdam Pharma is a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases. Pharmaceutical Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. Pharmaceutical

Pharmaceutical

New Amsterdam

Received Grant

Pharmaceutical

Novartis

Received Grant

Pharmaceutical

NovoNordisk

Biotechnology, pharmaceutical

Received Grant

Pharmaceutical

Pfizer

Biotechnology, pharmaceutical

Received Grant

Pharmaceutical

Regerenron

Biotechnology

Received Grant

Pharmaceutical

Sanofi

Pharmaceutical

Received Grant

Pharmaceutical

Satsuma

Biopharmaceutical

Received Grant

Pharmaceutical

Selecta

Biotechnology

Received Grant

Pharmaceutical

Shionogi

Pharmaceutical company

Received Grant

a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health.

Biopharmaceutical

Viking

Biopharmaceutical company

Received Grant

Pharmaceutical

Vivus

Biopharmaceutical

Received Grant

Home Access Health Corporation, which is now a subsidiary of Everly

Health, was founded to provide customers with health information through simple, self-collected lab tests Health Care

Laboratory Testing Legal Technology

Home Access

Received Grant Received Grant

Lexicon

Practice Management Software

Legal Technology

Metavante Technologies, Inc., through its subsidiary, Metavante Corporation, provided financial technology services, software and financial services regulatory advice and consulting to its customers, consisting primarily of small to large sized financial institutions. An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. The ASPC, founded in 1985, represents a multidisciplinary group of healthcare practitioners and researchers who share an interest in and a passion for preventive cardiology. Endocrine Society is a global community of endocrine investigators and clinicians focused on improving patient care, advancing research, shaping effective policy, and ensuring the future of endocrinology. The American College of Cardiology, a 49,000-member nonprofit medical society, enhances the lives of cardiovascular patients through continuous quality improvement, patient-centered care, payment innovation, and professionalism. The ADA's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. The National Lipid Association is a 501(c)(3) organization formed in 2008 to serve as a patient education organization in the field of clinical lipidology. Endocrine Society is a global community of endocrine investigators and clinicians focused on improving patient care, advancing research, shaping effective policy, and ensuring the future of endocrinology. The Pediatric Endocrine Society invites members to form Special Interest Groups (SIGs). SIGs provide a venue for members to network with other colleagues sharing similar interests, to provide a forum to discuss issues concerning topics relevant to the SIGs, and work towards goals that will benefit our patients and the membership of the Pediatric Endocrine Society at large. Company Description

Business Tools

Received Grant

Technology

Metavant

501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations

TIMI

Education

Received Grant

General Member, Fellow, Speaker

The Obesity Society (TOS)

Association

The American Society of Preventative Cardiology (ASPC)

501C-6 / 501C-3 Organizations

Association

Board Member, Fellow, Speaker

501C-6 / 501C-3 Organizations

The Endocrine Society

Association

Member

AACE is the organization focused on endocrinology, diabetes and metabolism that is most: Recognized worldwide for its clinical leadership Association

American Association of Clinical Endocrinologists (AACE)

501C-6 / 501C-3 Organizations

Member

501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations

American College of Cardiology (ACC)

Association

Member, Fellow, Speaker

American Diabetes Association (ADA)

Association

Member

501C-6 / 501C-3 Organizations

The National Lipid Association

Association

Producing a joint statement

Type

Relationship

Product

Company

Board Member

501C-6 / 501C-3 Organization+A69s

Marisa Censani

The Endocrine Society

Association

Member

Member, completed a three-year term as co-chair

501C-6 / 501C-3 Organization+A69s

Pediatric Endocrine Society (SIG)

Association

Product

Company

Company Description

Type

Relationship

Board Member

Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity.

Anthony Auriemma

Pharmaceuticals

Currax

Pharmaceutical

Speakers Bureau

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. Nestlé Health Science is a leader in the field of nutritional science, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer health, medical nutrition and supplement brands. Illinois Obesity Society is a group of health care professionals dedicated to improving the treatment of Obesity in Illinois.

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical

Speakers Bureau

Pharmaceuticals

Phenomix

Biotechnology, pharmaceutical

Consulting

Pharmaceuticals

Vivus

Biopharmaceutical

Speaker Bureau

Nutrition

Nestle Nutrition

Food and beverage

Consulting

501C-6 / 501C-3 Organizations

Illinois Obesity Society

Association

Board of Trustee Member

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly

Speakers Bureau

Product

Company

Type

Relationship

Board Member

Company Description

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Sandra Christensen

Pharmaceuticals

Eli Lilly

Advisory Board

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical

Speakers Bureau

The Washington Obesity Society is a coalition dedicated to creating a community resource for providers in the growing field of obesity medicine. Association

501C-6 / 501C-3 Organization+A69s

Washington Obesity Society

Trustee

AANP empowers all NPs to advance accessible, person-centered, equitable, high-quality health care for diverse communities through practice, education, advocacy, research and leadership.

501C-6 / 501C-3 Organization+A69s

the American Association of Nurse Practitioners (AANP).

Association

Member, speaker

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly

Speaker

Abbott Laboratories is an American multinational medical devices and health care company. AANP is the largest and only full service national professional membership organization for NPs of all specialties. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity. The American Academy of Pediatrics (AAP) and its member pediatricians dedicate their efforts and resources to the health, safety and well-being of infants, children, adolescents and young adults. The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. Course and consulting business to help physicians start obesity medicine practices The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” Company Description Company Description

Technology

Abbott Laboratories

Medical Device Company

Advisory Board

American Association of Nurse Practitioners

Professional Organization

Association

Education planner and fellow

Product

Company

Type

Relationship

Board Member

Suzanne Cuda

Pharmaceutical

NovoNordisk

Biotechnology, pharmaceutical

Advisory Board

Biotechnology, pharmaceutical

Gold Faculty

Pharmaceutical

Rhythm Pharmaceuticals

501C-6 / 501C-3 Organization+A69s 501C-6 / 501C-3 Organization+A69s

American Academy of Pediatrics

Association

Member

The Obesity Society (TOS)

Association

General Member

Product

Company

Type

Relationship

Board Member

Carolynn Francavilla Brown

Education

Weight Care Consulting

Health Care

Owner

501C-6 / 501C-3 Organization+A69s

American Medical Association (AMA)

Governing Council for private practice physicians

Association

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Pharmaceutical

Eli Lilly

Speakers Bureau

Product

Company

Type

Relationship

Board Member Michelle Freshwater Board Member

Company Description

Product

Company

Type

Relationship

Company Description

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Product sales in obesity medicine practice

Sylvia Gonsahn-Bollie

Pharmaceuticals

NovoNordisk

Biotechnology, pharmaceutical

Consulting

Education Healthcare

Shaklee Corporation

Health Care Health Care

Ambassador

Physicians.com

Medical director

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General

Executive Director of Clinical Research in obesity

Pharmaceutical

Eli Lilly

Product

Company

Type

Relationship

Board Member Bharti K. Shetye

Company Description

Product

Company

Type

Relationship

Board Member

Company Description

Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity. Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” Hims & Hers Health, Inc. is an American telehealth company that sells prescription and over-the-counter drugs online, as well as personal care products Medical educational company

Craig Primack

Pharmaceuticals

Currax

Pharmaceutical

Speakers Bureau

Biotechnology, Medical Device, diabetes

Pharmaceuticals

Gelesis

Advisory Board

Pharmaceuticals

Phenomix

Biotechnology, pharmaceutical

Advisor

Nutrition Education Education

Nestle Nutrition

Food and beverage

Co-Medical Director

Paradigm Pri-Med

Education

Faculty

Continuing medical education (CME) Education

CME Speaker

501C-6 / 501C-3 Organization+A69s

The Obesity Society (TOS)

Association

General Member

501C-6 / 501C-3 Organization+A69s

American Medical Association (AMA)

Association

Member

Senior Vice President of Weight Management

Pharmaceuticals

HIMS Company

Biotechnology

Action Item for Approval of the Consent Agenda and Supporting Documents Section:

Read and be prepared to vote on the consent agenda items

Rules of Order Policy Board Approved September 2017

Rules of Order for Board Meetings Quorum: Our bylaws state that a quorum is present if the majority of the board is present.

Order of the day: Each meeting will have an agenda which will include points to discuss, old business and new business. The leader of the meeting is referred to as the “Chair.” This may be the chairman of the board, the president, or the highest-ranking officer present at the meeting. Items to discuss: All board members may submit items to discuss. These items must be submitted at least 2 weeks prior to the scheduled meeting. Items must be submitted electronically as editable Microsoft word documents. Items must include: the person (or persons, committee, etc.) introducing the item and the date of submission. Items should be marked as informational items (board updates), discussion items (not asking for action), or action items. For action items, the specific action being requested by the board should be clearly indicated. Late items: From time to time, items of critical importance may need to be introduced within 2 weeks of the board meeting. These items will be marked in the board book as “Late” and will only be discussed after a majority vote of the board to discuss the item. Motions: Introducing a main motion 1) The chair may call on the person responsible for the next order of business. Or, when no one else has the floor, a board member may address the chair by proper title. After recognition by the chair, the board member may make a motion. 2) To make a motion, state, “I move that…,” and state your motion. For example, “I move that we discuss item #4 regarding updating our travel policy…” Regarding the above items of business, the person who introduced the item of business and who’s name appears on the item of business should introduce the motion. 3) Another member may second your motion. A second simply means that the motion should be discussed. If the motion is not seconded, it is not up for discussion. It is not lost, as there has been no vote. 4) Only if there is a second, the chair states “It has been moved and seconded that…” (state the motion). “Is there any discussion?” 5) Only one main motion may be on the floor at a time. Discussing a motion 1) All speaking points should be limited to 3 minutes. This will be enforced with a timer, and an OMA staff person will be designated to monitor the timer. A different time limit (or no time limit) may also be used if requested by a majority of the quorum, either for a single item of business, or for the entire meeting. 2) The member who made the motion is entitled to speak to it first. 3) Every member may speak to the motion. Only the motion at hand should be spoken either for or against. Each member should clearly state whether they are speaking for or against the motion. 4) A person may not speak against their own motion (however, they can vote against their own motion). 5) All discussion should be directed towards the motion. Avoid using a person’s name during the debate. 6) All questions should be directed to the chair. 7) Each member may only speak to the motion twice; however, asking a question or a brief suggestion does not count as that person’s debate.

Rules of Order Policy Board Approved September 2017

8) A person may only speak a third time with the chair’s permission. 9) Only the person who introduced the motion may speak again at the end (even if this is a third time). Voting on a motion 1) Before a vote is taken, the Chair puts the question to a vote by saying “Those in favor of the motion that… (repeat the motion) … say ‘Aye.’ Those opposed say ‘No.’” 2) Wait, then say “The motion is carried,” or “The motion is lost.” 3) If a member is in doubt about the result, he or she may call for “division.” A division is a demand for a standing vote count. This may be show of hands or ballot. 4) A majority is MORE than ½ of the votes cast by persons entitled to vote (a tie does NOT carry because it is not a majority). 5) A confidential written vote may be requested by any member of the board during in-person meetings. This would not require a second. Subsidiary Motions 1. Amending a motion a. Any main motion or resolution may be amended by: adding at the end, striking out or inserting words, substitution. b. To amend a motion, during discussion, a member may say “I move to amend the motion by…” Another member must second this amendment. c. The chair asks “Is there any discussion on the amendment? [repeat amendment].” At this point, only the amendment is discussed. d. When discussion ceases, the Chair says “Those in favor of the amendment [repeat amendment] say ‘Aye.’ Those opposed say ‘Nay.’ e. At this point, the motion carries or not. The main motion (amended or not) can now be voted on, discussion can continue, or the motion may be amended again (by another motion). f. Note, even if an amendment is passed, the main motion has still not been voted on – a separate vote is required. 2. Postpone definitely / indefinitely a. When the assembly does not want to take a position on the main question at all (indefinitely) b. When the assembly wants to delay to a certain time (definitely) 3. Motion to substitute a. When the assembly wishes to substitute a new motion for the original motion. 4. Refer a. Sends a pending motion to a committee, etc. 5. Limit debate / Extend debate 6. Lay the motion on the table (tabling the motion) a. This is used to lay the pending question aside and move on with other business. This may be appropriate when there is a more urgent question at hand, scheduling issue (people invited to speak to the board), etc. Privileged Motions 1. Call for order of the day – a member can interrupt a speaker to call for sticking with the agenda. 2. Recess – used to request an intermission (does not end the meeting)

Rules of Order Policy Board Approved September 2017

3. Adjourn – used to end the meeting. 4. Fix the time to Which to Adjourn – sets the time at which the meeting will adjourn; any unfinished business is moved to the next meeting. Incidental Motions 1. Point of order – used when member feels rules are being violated. Member may interrupt a speaker to raise a point of order. 2. Appeal – used to challenge the chair’s ruling. 3. Suspend the rules – example – suspend the time limit, allow other discussions, etc. 4. Withdraw – permits the maker of the motion to withdraw it. 5. Point of information – requests to the chair to provide information relevant to business at hand. A point of information must be in the form of a question. 6. Objection to consideration of a question – suppresses business that is irrelevant or inappropriate and undesirable to be discussed. Other Main Motions 1. Take from the table – resumes consideration of a motion laid on the table earlier. 2. Reconsider – reopens a motion to debate that has already been voted upon in the same session. 3. Rescind or amend – something previously adopted Other Rules of Conduct: 1. Be prepared – Carefully review the complete board manual before the board meeting. 2. Communicate prior to the meeting – Many items can be resolved before the meeting, saving valuable time. Or, big ticket items can be identified and proper time allocated. 3. Freedom of movement – Board members are welcome to stand, sit, or use the facilities as needed. 4. Freedom of opinion – Board members are free to express their opinions, without fear of stigmatization or personal attack by other board members. 5. Respect – Board members are expected to treat each other respectfully. 6. Attention – Board members are expected to pay attention. This requires turning off cell phones and other distracting electronic devices. Board members are expected not to be texting, emailing or making personal calls (barring emergency or urgent situations) during meetings. 7. Conflict of interest – If a real or perceived conflict exists, a board member must disclose this. Depending on the conflict, if the other board members feel the conflict is not germane to the item being discussed, the member may be allowed to discuss and vote. Other options – member may be allowed to discuss but not vote. Member may be not allowed to discuss or vote. Or, member may be asked to leave the board room for the discussion. The board should determine the level of conflict and appropriate level of involvement by the conflicted member on the issue at hand.

DEPARTMENT UPDATES OMA BOARD OF TRUSTEES (BOT) MEETING 10/25/2023 2D0e 2p 3a rEt md uecnatt iDoinr eacnt od rE: vJeona tns HU apbdlauttezse l Presented below is data related to OMA’s conferences and online education. We completed the update Et ot hoousr iOn MJ uAl yA2c0a 2d 3e m. Wy iat hn dt hl ai sunnec wh epdl ao tnf oar nme, ww Le eaarrenbi negt t Me raanbalgeetmo ef ancti lSiyt as tt ee mg r (oLuMp Sp)upr cl ahtaf os er smacnadl l e d aa rdema i anni sdt rtaotpi oi cns voifeowuirn gc oausrws eesl l(ai .se .t “r na cukt ri ni tgi oonf ”l)e taor nme ar sk.eWt heeasreeaarlcsho fbuentct et iro anba llei t yt om“ toarge” sbeya mt hlee scso. n t e n t We will also be using this transition time to shore up the content tagging and labeling of all of our ca or eu rhsoeps i. nWg et oh ga ev te ms toa sr tt ecdo ns et el enct t fi innga sl iezsesdi obnys Na on vdepml abnenr i onfg2c0o2n3t ewn it t fho ar tf he we 2s0l o2t4s As anvneuda tl oC foi nl l f learteenr cteo. W e a2 c0c2o4mFma lol dSautme ma ni ty wn ei twh i nu pt dh ae tne es xotrf e“ lwa t me bornetahks i ansg ”wseelsl ,sai onnds r. eTlha et i vs teatf of wt hi lel cboeng ti ne nt to fpo lratnh ceosnutme nmt ifto, rwteh e aOrveehrcoopminigngtoOgbeetssitoym2e0f2e3edCboancfkerfernocme ainttSeanndeAenstoonnitoh, eTmX.ain topic area of focus during the

C ONFERENCES

Fundamentals of Obesity Treatment - Virtual Live Registrations

100 150 200

143

141

136

125

123

90

0 50

Feb

July

November

2022 2023

*Registrations for Nov 2023 are still coming in

1 | Pa g e

Total Conference Registrations

San Antonio 2023

Anaheim 2022

Chicago 2021

Boston 2019

DC 2018

San Antonio 2017

1000

927 927

907

879

900

856

802 818

774

800

743 746

711

734

685

700

666

600

600

570 582

500

388 406 399

357 372

400

304 308 309

275 285

300

200

100

0

16151413121110 9

8

7

6

5

4

3

2

1 FINAL

# OF WEEKS OUT

*Note: Boston 2019, Washington, D.C. 2018, and San Antonio 2017 were all Fall Conferences inclusive of the ABOM Review Course

2 | Pa g e

OMA A CADEMY (LMS)

3 | Pa g e

O THER U PDATES

Partnership Grants

•12 in-person sessions focused on Motivational Interviewing •2 completed so far •$40,750 in funding Pri-Med

•In person session at OMA Spring 2023 •75 people registered •$32,580 in funding Peerview Medicical Communications •Several enduring courses launched March 2023 •$15,000 in funding Haymarket

•In person sessions (6 state chapter meetings, 20 local live meetings, 7 enduring sessions) •Focus on Patient Perspectives to Improve Obesity Management •$22,250 in funding CCO/PCE

•Submitting for RFP •Focus on Reducing CV Risk •Requesting $16k in funding PlatformQ Health Education

•Asking for extension of current program •Same format and topics •Requesting $40k in funding Pri-Med •Submitting for request from Lilly •Focusing on Patient Bias and Access to Care •Requesting $20k in funding CCO/PCE

4 | Pa g e

Products and Programs

New in 2023

In progress

New LMS (OMA Academy) 2023 Obesity Algorithm

Obesity 201 (update of current student rotation) Spring24 Content Planning

2023 Pediatric Obesity Algorithm

2024 Obesity Algorithm Update of SAP V1 Pediatric SAP

Updated Pocket Guidelines

Obesity 101 (geared towards CITs)

2024 Pediatric Obesity Algorithm

Patient Education Infographics

Annual Conference Dates and Locations

Fall Summit

Fall 2023

Fall 2024

Fall 2025

10/25-10/29/23

San Antonio, TX

Spring 2024

4/24-4/28/24

Denver, CO

10/24-10/26/2024

10/2-10/4/2025

Spring 2025

4/21-4/28/25

National Harbor, MD

Cedar Creek TX (outside of Austin)

Isle of Palms, SC

Sping 2026

4/6-4/13/26

San Diego, CA

Spring 2027

3/29-4/5/27

Orlando, FL

Fundamentals of Obesity Treatment--Virtual Live dates

2023

2024 February 16 &17 July 19 & 20 November 22 &23

November 17 &18

5 | Pa g e

2D0e 2p 3a rMt me me nbt eDr si rhei cpt oUrp: dCa ht er si s/tSi taant iDs tei Sc so u s a • Oa lMmAo sctoan 1t i 3n%u e gs rtoows et ht rt eh cr oo rudg hmtehme bf ier rsst ht ihpr eneu mq ubaerrt se resa. cWh emsounr tpha as sneddwo eu rc ul ar treesnt t ml y i hl easvt eo nhea dg o i n g over 5,000 total members and ending September with 5,054 total members. • Rb uett etnhti si oins shtai lsl baeneanrehao ltdhiantgws teeaardeysitnritvhien g72t o%i mrapnrgoevewohni c. h i s up fro m 63% a t t he s t a rt o f 20 2 1, • TJ uhl ye on fe w2 0m2 3e ma nbde rt shhe i pm (eams sboecr isaht ii po na nmda mn aagrekme tei nn gt st ye sa tme ms a) rpe l ac ot fnotrimn u, iFnogntthe ev iar, ww oa rs kl awu int hc hveadr il oa ut es cuopma pn od nreunntns i on fg tahnednaenwi ns oi tfitawl amr ee m. Abne er wc oPl lraobvoi rdaetri oDni rgercotuopr ywainl ldbMe ef uml lby efru nRcetsi oounracl esso soenc. t i o n i s Dp oi st ceunst si ai ol ng rs owu ipl ls oscuccuhr aass rteoghi oonwa lwbea sweadn, tt ot op i uc tbi lai zs ee dt h, oi sr cpool tl ae bn ot iraal tl yi ouns teodoal smaocvoi nn gd uf oi tr wt oa r d f o r reinvigorate our Mentorship Program. • Wl o ne ghearvqeuianlci frye af os re dt hoi us rb Ce nI Te fUi tptghraatdwe aonf ftetro t uo p7g5r%a d oe ftf of oorntehoe f f oi rusrt cylei na ri cfioa rn tmh oesme bCeI rTsshwi phtoy pn eos f o r the first year. Just a handful have taken advantage of this offer thus far. • Wc o en caerpe twvoi ar kZionogmwti ht ha tt hwei lMl heampbpeerns he ii pt hCe or mmmo ni tttheley toor dqeuvaerltoepr lay “aNnedwwMi l lebmebaedr dHe adptpoyoHu ro uc ur ”r r e n t nb ue wt wmeesmt i bl l ehroopnebtooalraduinncghparno gi rnai tmi a. lTvheirsshi oans bbeefeonr ea tbhiet dyeelaaryeenddws .i t h t h e s o f t w a r e c o n v e r s i o n , • Nc heawn gmi negmmb ee rms hb iepr tt yy pp ee ss hf raovme b“ Ve eont i nd ge ”v ev leorps euds “bNy oanw- Voor tki inngg” gwr iot uh pp oh fy tshi cei aBnOmT ef omc bu es er sd roenq u i r e d tmo ebme bpearrsthoi pf tfhoer “aVvoot ti ne gi n” geraorul yp .2T0 h2i4s wmiet mh tbheer shhoi pp ec thhaantgteh we siel l cbhea inngter so dwui cl legdot oi nttho ee Of f Me cAt b y t h e sr ee tcaoinndi nqgutahret eOrMo Af 2’ s0A2M4 . AT Hh iOs Dc hsaenagt ea fi tne mr tehme bneerxst hf ii pv et -yypeeasr srhe ov ui el dw swi ghni icf hi c iasndt luyeaisns i2s0t 2i n6 . 2 D 0 e 2 p 3 a rMt ma reknet tMi nagn/aPguebrl:i cKRaet lhartyi onn(sK(aPtRy )) UR pu dd az itne ss /kSi t a t i s t i c s Me xacrekeedtei nd gt hCea mt opt aa li gr ne sv :e nBuyeMf raoymo ft h2e0 2e 3n ,t ior ue ryme aornot fh 2l y0 m2 2e mm bo enrt shhl yi pmc ea mm bp ea ri gs nh si pr ec av me npuaei ghnasd. Ta hl reesaed y cwaimt hpaani gendsuacraet idoenpbl ouyneddl et .hWr oeu cgohnetmi nauiel at on dr eovfifeewr cduasttao mf r oe mr s tahdeissec oc aumn tpoani gmn se ma nbde cr sohnispi d, oe frt ehno wp atior e d iot regraa nt ei ztaht ei os ne adl etlai vl eenr ta bp li epse li inn feuet ua rr ley ci anmt hpea iygenasr. , Ww iet hb raocuhgahnt gme ai nr kt ehtei nmg acrokoert di ni ng adt eo pr aNr itcmh ee nVt e’ sr a l d i o n t o tmhoe rtee ac mo h we siitvhe t ahpe pi nr ot ea nc ht i ot on porf obj reicnt gs i ansg oouurr mg raarpkhe itci ndge tsei ganmppraorj et nc et sr si nf -rhoomu ss et a. rTthtios fhi na si shhewl piet hd ot ou rf o r m a ecodnufcearteionncetemaamrktoetuinpgdfartoemexbisetgiinngnainsgwteolleansdd. evelop new projects with our events team to design Digital Marketing: In 2023, we shifted our digital campaign strategy to follow a quarterly cadence, df orci vu es ne dp or inmcaorni lfye rbeyn cc oe nr feegries nt rcaet idoenasd al innde so. nWOeMa Al t emr ne amt eb eqrus ahri tpe. rOs ubre ct wa me epna iagdnvs etrht ii ss iynega cr ahma pv ea ibg enes n

6 | Pa g e